← Open Payments lookup

MICHELLE MORTON: Open Payments

NPI 1417423765 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,725 in 76 payments from 16 companies in 2025. Trend: 2023 $1,373 · 2024 $2,556 · 2025 $2,725

Food & beverage: $2,088Speaker / faculty: $638
CompanyPaymentsAmount
Ipsen Biopharmaceuticals, Inc7$761
Madrigal Pharmaceuticals12$527
Gilead Sciences, Inc.19$478
ABBVIE INC.13$227
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$226
Novo Nordisk Inc1$122
E.R. Squibb & Sons, L.L.C.1$121
Eisai Inc.3$80
Alkermes, Inc.1$31
Boston Scientific Corporation1$29

Products named: IQIRVO, REZDIFFRA, MAVYRET, XIFAXAN, Lenvima, VIVITROL, Resolution 360 Clip, CUVRIOR.

Industry payments across TX — which companies pay providers there.